Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer
- 30 November 2008
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 41 (16-17) , 1335-1341
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Involvement of CD44, a molecule with a thousand faces, in cancer disseminationSeminars in Cancer Biology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and managementInternational Journal of Clinical Oncology, 2005
- MULTIFOCAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND UPPER URINARY TRACT: MOLECULAR SCREENING OF CLONAL ORIGIN BY CHARACTERIZING CD44 ALTERNATIVE SPLICING PATTERNSJournal of Urology, 2004
- Clinical utility of cytokeratins as tumor markersClinical Biochemistry, 2004
- Urinary markers of bladder carcinomaClinica Chimica Acta, 2004
- Comparison of Telomerase Activity and Matrix Metalloproteinase-9 in Voided Urine and Bladder Wash Samples as a Useful Diagnostic Tool for Bladder CancerEuropean Urology, 2003
- Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markersCurrent Opinion in Obstetrics and Gynecology, 2003
- Bladder cancer in Africa: UpdateSeminars in Oncology, 2001
- Molecular Detection of Cancer Cells by Competitive Reverse Transcription-Polymerase Chain Reaction Analysis of Specific CD44 Variant RNAsJNCI: Journal of the National Cancer Institute, 1998